Trimebutine is a drug with antimuscarinic and weak mu opioid agonist effects.The maleic acid salt of trimebutine is marketed under the trademark of Debridat, Recutin, Polybutin or Modulon for treatment of irritable bowel syndrome and other gastrointestinal disorders. The major product from drug metabolism of trimebutine in human beings is nor-trimebutine, which comes from removal of one of the methyl groups attached to nitrogen. Trimebutine exerts its effects in part due to causing a premature activation of phase III of the migrating motor complex in the digestive tract. Both Trimebutine and its metabolite are commercially available.
CAS:39133-31-8
Specification:98%
Molecular Formula:C22H29NO5
Formula Weight:387.47g/mol
More about Trimebutine .
No comments:
Post a Comment